Editor: Justine R. Smith, MD, PhD (American Uveitis Society AAO Education Liaison)
The following 10 uveitis papers published in 2010 were selected by members of the American Uveitis Society (AUS) for their outstanding teaching value for residents.
Daniel E, Thorne JE, Newcomb CW, Pujari SS, Kaçmaz RO, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Foster CS, Jabs DA, Kempen JH. Mycophenolate mofetil for ocular inflammation. Am J Ophthalmol. 2010;149:423-32.e1-2.
Foster CS, Davanzo R, Flynn TE, McLeod K, Vogel R, Crockett RS. Durezol (Difluprednate Ophthalmic Emulsion 0.05%) compared with Pred Forte 1% ophthalmic suspension in the treatment of endogenous anterior uveitis. J Ocul Pharmacol Ther. 2010;26:475-83.
Kaçmaz RO, Kempen JH, Newcomb C, Daniel E, Gangaputra S, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Jabs DA, Levy-Clarke GA, Foster CS. Cyclosporine for ocular inflammatory diseases. Ophthalmology. 2010;117:576-84.
Lasave AF, Díaz-Llopis M, Muccioli C, Belfort R Jr, Arevalo JF. Intravitreal clindamycin and dexamethasone for zone 1 toxoplasmic retinochoroiditis at twenty-four months. Ophthalmology. 2010;117:1831-8.
Lin P, Loh AR, Margolis TP, Acharya NR. Cigarette smoking as a risk factor for uveitis. Ophthalmology. 2010;117:585-90.
Pavesio C, Zierhut M, Bairi K, Comstock TL, Usner DW; Fluocinolone Acetonide Study Group. Evaluation of an intravitreal fluocinolone acetonide implant versus standard systemic therapy in noninfectious posterior uveitis. Ophthalmology. 2010 Mar;117:567-75, 575.e1.
Pujari SS, Kempen JH, Newcomb CW, Gangaputra S, Daniel E, Suhler EB, Thorne JE, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Foster CS. Cyclophosphamide for ocular inflammatory diseases. Ophthalmology. 2010;117:356-65.
Thorne JE, Woreta FA, Dunn JP, Jabs DA. Risk of cataract development among children with juvenile idiopathic arthritis-related uveitis treated with topical corticosteroids. Ophthalmology. 2010;117:1436-41.
Zaidi AA, Ying GS, Daniel E, Gangaputra S, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Kempen JH; Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study. Hypopyon in patients with uveitis. Ophthalmology. 2010;117:366-72.
Zamecki KJ, Jabs DA. HLA typing in uveitis: use and misuse. Am J Ophthalmol. 2010;149:189-193.e2.
An American Uveitis Society Publication
Contributors: Nisha Acharya, MD, MS; Thomas A. Albini, MD; Esen K. Akpek, MD; Emmett T. Cunningham MD, PhD, MPH; Albert O. Edwards, MD, PhD; Anthony S. Ekong, MD; Jose A. Flores-Guevara, MD; Harry W. Flynn Jr., MD; C. Stephen Foster, MD; Roger K. George, MD; Debra A. Goldstein, MD; Gary N. Holland, MD; Douglas A. Jabs, MD, MBA; Guy Jirawuthiworavong, MD, MA; Brian C. Joondeph, MD; John H. Kempen, MD, MPH, MHS, PhD; Leila I. Kump, MD; Kashyap B. Kansupada, MD; Shree K. Kurup, MD; Daryl E. Kurz, MD; Paul A. Kurz, MD; Paul Latkany, MD; Julie F. Leigh, MD; Richard A. Lewis, MD, MS; Ralph Levinson, MD; Careen Y. Lowder, MD, PhD; Todd P. Margolis, MD, PhD; Ramana S. Moorthy, MD; Robert B. Nussenblatt, MD; E. Mitchel Opremcak, MD; Alan G. Palestine, MD; Jose S. Pulido, MD; Russell Read, MD, PhD; H. Nida Sen, MD, MHSc; Mark D. Sherman, MD; Justine R. Smith, MBBS, PhD; Richard F. Spaide, MD; Lucia Sobrin, MD, MPH; Eric Suhler, MD, MPH; Donald U. Stone, MD; Howard H. Tessler, MD; Jennifer E. Thorne, MD, PhD; Albert T. Vitale, MD; Jonathan D. Walker, MD; R. Christopher Walton, MD; Russell Van Gelder, MD, PhD; Ira G. Wong, MD, MS.